John Varga

John Varga

University of Michigan-Dearborn

H-index: 105

North America-United States

About John Varga

John Varga, With an exceptional h-index of 105 and a recent h-index of 59 (since 2020), a distinguished researcher at University of Michigan-Dearborn, specializes in the field of fibrosis, scleroderma, metabolism, aging, precision medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Physical activity during COVID-19 in people with systemic sclerosis: A Scleroderma Patient-centred Intervention Network COVID-19 Cohort longitudinal study

Protocol for the Development of a Tool to Map Systemic Sclerosis Pain Sources, Patterns, and Management Experiences: A Scleroderma Patient-Centered Intervention Network Patient …

Morphological Reprogramming of Primary Cilia Length Mitigates the Fibrotic Phenotype in fibroblasts across diverse fibrotic conditions

TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease

A qualitative interview study exploring the psychological health impacts of the SPIN-CHAT program among people with systemic sclerosis at the onset of COVID-19: perceptions of …

Perspective to precision medicine in scleroderma

Cellular and Molecular Mechanisms of Fibrosis in Systemic Sclerosis

Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis

John Varga Information

University

Position

___

Citations(all)

47759

Citations(since 2020)

17690

Cited By

37347

hIndex(all)

105

hIndex(since 2020)

59

i10Index(all)

330

i10Index(since 2020)

225

Email

University Profile Page

University of Michigan-Dearborn

Google Scholar

View Google Scholar Profile

John Varga Skills & Research Interests

fibrosis

scleroderma

metabolism

aging

precision medicine

Top articles of John Varga

Title

Journal

Author(s)

Publication Date

Physical activity during COVID-19 in people with systemic sclerosis: A Scleroderma Patient-centred Intervention Network COVID-19 Cohort longitudinal study

Journal of Scleroderma and Related Disorders

Amanda Wurz

Richard S Henry

Linda Kwakkenbos

Marie-Eve Carrier

Scott B Patten

...

2024

Protocol for the Development of a Tool to Map Systemic Sclerosis Pain Sources, Patterns, and Management Experiences: A Scleroderma Patient-Centered Intervention Network Patient …

Tiffany Dal Santo

Meira Golberg

Elsa-Lynn Nassar

Marie-Eve Carrier

Sophie Hu

...

2024/4/15

Morphological Reprogramming of Primary Cilia Length Mitigates the Fibrotic Phenotype in fibroblasts across diverse fibrotic conditions

bioRxiv

Priyanka Verma

Bharat Yalavarthi

Swati Bhattacharyya

Dinesh Khanna

Johann E Gudjonsson

...

2024

TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease

The American Journal of Pathology

Amanda S Pellowe

Michelle J Wu

Tae-Yun Kang

Tracy D Chung

Adrian Ledesma-Mendoza

...

2024/3/26

A qualitative interview study exploring the psychological health impacts of the SPIN-CHAT program among people with systemic sclerosis at the onset of COVID-19: perceptions of …

Disability and Rehabilitation

Amanda Wurz

Delaney Duchek

Kelsey Ellis

Mannat Bansal

Marie-Eve Carrier

...

2024/1/30

Perspective to precision medicine in scleroderma

Frontiers in Immunology

Kazuhiro Komura

Koichi Yanaba

Jean-David Bouaziz

Ayumi Yoshizaki

Minoru Hasegawa

...

2024/1/18

Cellular and Molecular Mechanisms of Fibrosis in Systemic Sclerosis

Maria Trojanowska

John Varga

David Lagares

2024/4/24

Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis

Nature Communications

Feiyang Ma

Pei-Suen Tsou

Mehrnaz Gharaee-Kermani

Olesya Plazyo

Xianying Xing

...

2024/1/3

Introduction: The etiopathogenesis of systemic sclerosis—An integrated overview

Carol Feghali-Bostwick

David J Abraham

John Varga

2024/4/24

Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network …

EClinicalMedicine

Robyn K Wojeck

Mitchell R Knisely

Donald E Bailey

Tamara J Somers

Linda Kwakkenbos

...

2023/8/1

LUNG CANCER IN SCLERODERMA: RISK FACTORS AND OUTCOMES

CHEST

Anthony J Esposito

Ray Goodwin

John Varga

Jungwha Lee

JANE E DEMATTE D AMICO

2023/10/1

Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis

Rheumatology

Christopher P Denton

Francesco Del Galdo

Dinesh Khanna

Madelon C Vonk

Lorinda Chung

...

2023/1/1

Reduced SPAG17 expression in systemic sclerosis triggers myofibroblast transition and drives fibrosis

Journal of Investigative Dermatology

Paulene Sapao

Elisha DO Roberson

Bo Shi

Shervin Assassi

Brian Skaug

...

2023/2/1

Elevated Levels of Mitochondrial DNA and CGAS Ligands Are Found in Scleroderma Associated Interstitial Lung Disease and Mediate Fibroblast Activation

S Yu

S Woo

B Hu

Y Sun

V Fiorini

...

2023/5

Extracellular Matrix–Derived Damage-Associated Molecular Patterns: Implications in Systemic Sclerosis and Fibrosis

Swarna Bale

Priyanka Verma

John Varga

Swati Bhattacharyya

2023/7/14

IS THE DEGREE OF SKIN FIBROSIS MEASURED BY THE MODIFIED RODNAN SKIN SCORE DIFFERENT BETWEEN PATIENTS WITH PROGRESSIVE SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE?

CHEST

Oriana Salamo

Rodeo A Abrencillo

Elana Bernstein

John Varga

Francesco Boin

...

2023/10/1

Circulating Ctrp9 is associated with severity of systemic sclerosis–associated interstitial lung disease

Arthritis care & research

Monica M Yang

Lauren C Balmert

Roberta Goncalves Marangoni

Mary Carns

Monique Hinchcliff

...

2023/1

Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups

Rheumatology

Susan L Murphy

Yen T Chen

Yvonne C Lee

Mary Carns

Kathleen Aren

...

2023/2/1

1088 Bardoxolone improves investigative SSc fibrosis

Journal of Investigative Dermatology

K Komura

J Varga

2023/5/1

Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis

JCI insight

Swarna Bale

Priyanka Verma

Bharath Yalavarthi

Scott Arthur Scarneo

Philip Hughes

...

2023/7/7

See List of Professors in John Varga University(University of Michigan-Dearborn)

Co-Authors

H-index: 165
Philipp E Scherer

Philipp E Scherer

University of Texas Southwestern Medical Center

H-index: 136
Jouni Uitto

Jouni Uitto

Thomas Jefferson University

H-index: 112
Sanjiv J. Shah

Sanjiv J. Shah

Northwestern University

H-index: 69
maria trojanowska

maria trojanowska

Boston University

H-index: 67
GR Scott Budinger

GR Scott Budinger

North Western University

academic-engine